BiO2 Medical is a start-up medical device company funded through a combination of Angel Investor funding, Venture Capital funds, as well as personal investments from the founders. Additionally, BiO2 Medical has received $1M in funding from the State of Texas through the Emerging Technology Fund for early-stage demonstration of the device concept.
The lead investor in BiO2 Medical is Incyte Ventures Targeted Technology Fund. Incyte Ventures focuses on investing in and accelerating the development of promising early stage life science companies. Incyte worked with the company’s investment bank, Karutz Flavin Wells, to finance the recent $7.5 million preferred equity round.
BiO2 Medical has also been awarded an IRS tax grant under the Qualified Therapeutic Discovery Projects program launched by the Obama Administration, which has granted BiO2 Medical roughly $244,479 in non-dilutive capital geared for R&D expenses.